Healthcare and Life Science
Answer the call for speakers & start-ups for CW's International Conference
Don't miss this opportunity to feature as a speaker or to showcase your start-up business at the upcoming Cambridge Wireless International Conference (CWIC), taking place on 27 March 2025 at Hinxton Hall, Cambridgeshire. ...
New technology enhances hearing aid fittings at Hearing Healthcare Centre
As the prevalence of hearing loss continues to rise, especially in older adults, the demand for innovative and effective solutions has become paramount. Hearing Healthcare Centre understands the critical role of personalised care, making it their mission to incorporate cutting-edge hear...
Strategies for combination therapy in oncology – Part three: Thinking outside the box
This article is published in PM360
SolasCure and U.S. Army Institute of Surgical Research collaborate for combat wound care
The collaboration will evaluate Aurase Wound Gel for the treatment of infected wounds in combat field care scenarios Cambridge, UK and Texas, USA, 06 November 2024: SOLASCURE Ltd, a biotechnology company developing a novel treatment to transform chronic wound care and the U.S. Army ...
The economic cost of living with a rare disease across Europe
Although rare diseases affect a relatively small number of patients, collectively there are an estimated 30 million people in Europe living with 6,000-7,000 known rare diseases (RDs). There is growing recognition of rare diseases as a public health concern, given the many social, mental...
Price achieved for first indication vs. ASMR
CRA Life Sciences continues its series on leveraging RADAR, its orphan drug data repository, with a focus on PMA trends between ASMR outcomes and average annual treatment costs. The analysis shows a clear correlation between the ASMR rating and the level of price achieved. Notably, ASMR...
Improving patient access to medicines targeting early-stage cancers in Europe
This article was published in ISPOR Value and Outcomes Spotlight
Uptake of advanced therapies in psoriasis and psoriatic arthritis
he uptake of innovative advanced treatments in immunology is highly dependent on the indication, with new innovative treatments gaining market share quickly in psoriasis, while older entrenched products still hold considerable market share in psoriatic arthritis. CRA analytics insight ...
Esther Hiller joins Salus Wellness
Salus Wellness is excited to welcome Esther Hiller to Salus Wellness this month.
Nuclera’s eProtein Discovery system installed at Domainex to streamline protein production services
Domainex is the first CRO to have installed the eProtein Discovery system Installation of Nuclera’s technology expands Domainex’s protein production services Cambridge, UK, 04 November 2024: Nuclera, the biotechnology company accelerating protein expression and optimization throu...